
Muthoot Finance share price declines 5% despite stellar Q4 earnings
Muthoot Finance, India's largest gold loan company, delivered a strong performance for the quarter as well as financial year ended March 31, 2025. Despite the strong fundamentals, its shares fell over 5 percent on Thursday, May 15, amid overall weak market sentiment.
For the March quarter (Q4FY25), the Kerala-headquartered firm reported a 22 percent year-on-year increase in consolidated net profit at ₹ 1,444 crore, up from ₹ 1,182 crore in the same quarter last year. This surge was supported by robust growth in its lending portfolio. On a standalone basis, net profit stood at ₹ 1,479 crore, marking a 41 percent rise compared to ₹ 1,050 crore in the year-ago quarter.
The company's consolidated assets under management (AUM) jumped 37 percent year-on-year to ₹ 1.22 lakh crore, while standalone AUM surged 41 percent to ₹ 1.06 lakh crore. Muthoot's gold loan portfolio continued to be its main growth driver, with gold loan AUM reaching an all-time high of ₹ 1,02,956 crore—a 41 percent jump over the previous year.
Annual consolidated profit after tax for FY25 stood at ₹ 5,352 crore, up 20 percent from ₹ 4,468 crore last year. Standalone profit also saw a sharp 28 percent rise to ₹ 5,201 crore. The company reported its highest-ever interest income of ₹ 15,586 crore for the year, reflecting strong customer repayment trends and an expanding lending base.
In terms of operational metrics, Muthoot Finance achieved multiple milestones. The average gold loan AUM per branch touched a new high of ₹ 21.21 crore. The company disbursed ₹ 21,888 crore in gold loans to nearly 18 lakh new customers during the year—both the highest-ever figures in its history. The total gold pledged as security in Muthoot's lockers reached 208 tonnes.
To reward shareholders, Muthoot Finance declared its highest-ever dividend of 260 percent, translating to ₹ 26 per equity share of face value ₹ 10 each.
However, performance from its subsidiaries presented a mixed picture. The group's microfinance arm, Belstar Microfinance, reported a 20 percent decline in AUM to ₹ 7,980 crore, down from ₹ 10,023 crore in the previous year. The subsidiary also saw its annual net profit shrink sharply to ₹ 46 crore from ₹ 340 crore amid industry-wide stress and asset quality concerns.
Despite the exceptional earnings report, Muthoot Finance shares dropped as much as 5.1 percent to ₹ 2,139.20 on the BSE. The stock remains over 12 percent below its 52-week high of ₹ 2,444.65 touched in March 2025. It has gained 35 percent from its 52-week low of ₹ 1,580 hit in June 2024.
On a yearly basis, the stock is still up over 34 percent. But it has struggled in recent months—down around 1 percent so far in May after a 9 percent correction in April. This follows a 12 percent rally in March, a 5.5 percent decline in February, and a 5.7 percent gain in January.
Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
38 minutes ago
- Time of India
Bajaj Housing Finance's net profit up 20.86% in Q1 FY26
NEW DELHI: Bajaj Housing Finance has reported a growth of 20.86 per cent in its net consolidated profit in the first quarter of the financial year 2025-26. The company's profit after tax stood at ₹583.30 crore in Q1 FY26 as against ₹482.61 crore it registered in the corresponding quarter of the previous fiscal, the company said in a BSE filing. The company's net consolidated total income stood at ₹2,618.45 crore in Q1 FY26, a growth of 18.55 per cent from ₹2,208.73 crore it recorded in the similar quarter last year. As of June 30, 2025, the company's net worth stood at ₹20,508.37 crore, debt-equity ratio was 4.31, total debts to total assets was 0.81, gross non-performing assets (NPA) was 0.30%, net NPA was 0.13%, capital to risk-weighted assets ratio was 26.94% and liquidity coverage ratio was 210.57%. The company's assets under management (AUM) grew by 24 per cent to ₹1.20,420 crore as of 30 June 2025 from ₹97,071 crore as of 30 June 2024. Loan losses and provisions for Q1 FY26 was ₹41 crore as against ₹10 crore in Q1 FY25. Provisioning coverage ratio on stage 3 assets at 56%.
&w=3840&q=100)

Business Standard
an hour ago
- Business Standard
Discovery Global Management exits SpiceJet, sells 2.2% stake for ₹119 crore
Global macro hedge fund Discovery Capital Management on Wednesday exited SpiceJet by selling its entire 2.2 per cent stake in the domestic carrier for₹ 119 crore through an open market transaction. The US-based Discovery Capital Management through its affiliate Discovery Global Opportunity (Mauritius) Ltd offloaded 3,11,53,621 shares, representing a 2.20 per cent stake in Gurugam-based SpiceJet, as per the bulk deal data on the BSE. The transaction was executed at an average price of ₹38.14 apiece, taking the total deal value to ₹118.82 crore. Meanwhile, Plutus Wealth Management bought 2.45 crore shares or 1.73 per cent stake in SpiceJet for ₹93.39 crore. The shares were picked up at an average price of ₹38.12 apiece. Following the stake buy, Plutus Wealth Management's holding in SpiceJet rose to 4.44 per cent from 2.71 per cent. Details of other buyers of SpiceJet shares could not be ascertained on the bourse. SpiceJet rose 5.75 per cent to close at ₹40.29 apiece on the BSE. On Wednesday, the Supreme Court dismissed a plea of KAL Airways and Kalanithi Maran seeking damages of over ₹1,300 crore from SpiceJet in a long-standing share transfer dispute. A bench of Justices P S Narasimha and A S Chandurkar upheld the Delhi High Court's order of May 23 dismissing their plea on grounds of delay. KAL Airways and Kalanithi Maran had initially sought damages of over ₹1,300 crore during the arbitration proceedings. Maran and KAL Airways were former promoters of SpiceJet.


The Hindu
2 hours ago
- The Hindu
Natco Pharma to acquire stake in South African firm Adcock Ingram for ₹2,000 crore
Natco Pharma has made an offer to acquire nearly 36% stake in South African pharmaceutical company Adcock Ingram Holdings (AIHL) for $226 million (around ₹2,000 crore). The proposal to acquire the stake from minority shareholders in an all cash deal is a strategic investment aimed at to expanding geographic footprint in South Africa, Natco said on Wednesday. Founded in 1890, AIHL has a diverse product portfolio, from generic and branded formulations, critical-care hospital products to consumer and home-care products. It operates across four segments -prescription, consumer, OTC and hospitals. The acquisition is expected to be completed by 2025. Post-acquisition, AIHL will continue to operate as a private South African business with Bidvest holding 64.25% and Natco 35.75%, including a prior held 0.80% stake, in the company. Post-transaction, Natco will consolidate 35.75% of AIHL net profits in its financial results. AIHL clocked revenue of $536 million in the financial year June 2024 and profit after tax of $45 million. 'Adcock Ingram is a respectable pharmaceutical company with well-recognised brands and products and maintains a leading position in the South African pharmaceutical market. The proposed transaction will provide Natco Pharma with a well-established entry into the Southern African market. It will also allow us to tap into new revenue streams and expand our footprint in one of the largest and growing emerging markets, while providing a gateway to the African continent,' CEO and Vice-Chairman Rajeev Nannapaneni said. Besides the acquisition, Natco Pharma Board also approved a proposal to incorporate a wholly owned subsidiary in South Africa with an investment of up to Rs.2,100 crore by this year to enter new geographies for growth and increased profitability. It also approved a proposal to liquidate wholly owned subsidiary Time Cap Overseas (TCOL), and directly hold the investment in step down subsidiary NatcoFarma do Brasil. Natco shares closed 2.01% higher at ₹1,034.75 apiece on the BSE.